Hormone regulation of microglial cell activation: Relevance to multiple sclerosis

Brain Research Reviews

Volumn 48, Issue 2, 2005, Pages 322-327

  Drew, Paul D ^a   Storer, Paul D ^a   Xu, Jihong ^a   Chavis, Janet A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cytokine; Hormone; Microglia; Multiple sclerosis; Nitric oxide; PPAR

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALITRETINOIN; CIGLITAZONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; PROSTAGLANDIN A2; RETINOID; TROGLITAZONE;

AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL VIABILITY; CONFERENCE PAPER; DIABETES MELLITUS; DRUG EFFECT; ENCEPHALITIS; HORMONE ACTION; HUMAN; LEUKOCYTE; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 17844395680     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2004.12.020     Document Type: Conference Paper

References (49)

1. 2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms J. Neurochem. 87 2003 742 751
2. 2 in the regulation of microglial functions Eur. J. Neurosci. 12 2000 2215 2223
3. 2 in activated murine macrophages Mol. Cell. Biol. 20 2000 1692 1698
4. S. Chandler, K.M. Miller, J.M. Clements, J. Lury, D. Corkill, D.C. Anthony, S.E. Adams, and A.J. Gearing Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview J. Neuroimmunol. 72 1997 155 161
5. N.G. Chen, and X. Han Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium Biochem. Biophys. Res. Commun. 282 2001 717 722
6. N.G. Chen, S.F. Sarabia, P.J. Malloy, X.Y. Zhao, D. Feldman, and G.M. Reaven PPAR-gamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression Biochem. Biophys. Res. Commun. 263 1999 718 722
7. R.B. Clark, D. Bishop-Bailey, T. Estrada-Hernandez, T. Hla, L. Puddington, and S.J. Padula The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses J. Immunol. 164 2000 1364 1371
8. J.M. Clements, J.A. Cossins, G.M. Wells, D.J. Corkill, K. Helfrich, L.M. Wood, R. Pigott, G. Stabler, G.A. Ward, A.J. Gearing, and K.M. Miller Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumor necrosis factor-alpha inhibitor J. Neuroimmunol. 74 1997 85 94
9. C.K. Combs, D.E. Johnson, J.C. Karlo, S.B. Cannady, and G.E. Landreth Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR-gamma agonists J. Neurosci. 20 2000 558 567
10. M.L. Cuzner, D. Gveric, C. Strand, A.J. Loughlin, L. Paemen, G. Opdenakker, and J. Newcombe The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution J. Neuropathol. Exp. Neurol. 55 1996 1194 1204
11. B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocr. Rev. 20 1999 649 688
12. 2 ameliorates experimental autoimmune encephalomyelitis J. Immunol. 168 2002 2508 2515
13. A. Diab, R.Z. Hussain, A.E. Lovett-Racke, J.A. Chavis, P.D. Drew, and M.K. Racke Ligands for the peroxisome proliferator-activated receptor-γ and the retinoid receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis J. Neuroimmunol. 148 2004 116 126
14. 2 represses nitric oxide, TNF-α, and IL-12 production by microglial cells J. Neuroimmunol. 115 2001 28 35
15. P. Duquette, and M. Girard Hormonal factors in susceptibility to multiple sclerosis Curr. Opin. Neurol. Neurosurg. 6 1993 195 201
16. D.L. Feinstein, E. Galea, V. Gavrilyuk, C.F. Brosnan, C.C. Whitacre, L. Dumitrescu-Ozimek, G.E. Landreth, H.A. Pershadsingh, G. Weinberg, and M.T. Heneka Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis Ann. Neurol. 51 2002 694 702
17. K. Gijbels, R.E. Galardy, and R.E. Steinman Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases J. Clin. Invest. 94 1994 2177 2182
18. N. Godessart, and S.L. Kunkel Chemokines in autoimmune disease Curr. Opin. Immunol. 13 2001 670 675
19. S.G. Harris, and R.P. Phipps The nuclear receptor PPAR-gamma is expressed by mouse T lymphocytes and PPAR-gamma agonists induce apoptosis Eur. J. Immunol. 31 2001 1098 1105
20. S.G. Harris, R.S. Smith, and R.P. Phipps 15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway J. Immunol. 168 2002 1372 1379
21. M.T. Heneka, D.L. Feinstein, E. Galea, M. Gleichmann, U. Wullner, and T. Klockgether Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase J. Neuroimmunol. 100 1999 156 168
22. A.K. Hewson, T. Smith, J.P. Leonard, and M.L. Cuzner Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790 Inflamm. Res. 44 1995 345 349
23. S. Hortelano, A. Castrillo, A.M. Alvarez, and L. Bosca Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages J. Immunol. 165 2000 6525 6531
24. S.M. Jackson, F. Parhami, X.P. Xi, J.A. Berliner, W.A. Hsuch, R.E. Law, and L.L. Demer Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction Arterioscler., Thromb., Vasc. Biol. 19 1999 2094 2104
25. C. Jiang, A.T. Ting, and B. Seed PPAR-γ agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86
26. Y. Kamei, L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.C. Lin, R.A. Heyman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors Cell 85 1996 403 414
27. T.K. Kerppola, D. Luk, and T. Curran Fox is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro Mol. Cell. Biol. 13 1993 3782 3791
28. E.J. Kim, K.J. Kwon, J.Y. Park, S.J. Lee, C.H. Moon, and E.J. Baik Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2 Brain Res. 941 2002 1 10
29. U. Kintscher, S. Goetze, S. Wakino, S. Kim, S. Nagpal, R.A. Chandraratna, K. Graf, E. Fleck, W.A. Huseh, and R.E. Law Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes Eur. J. Pharmacol. 401 2000 259 270
30. 12,14-prostaglandin J2 acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells Brain Res. 867 2000 115 121
31. A. Maeda, and R.A. Sobel Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions J. Neuropathol. Exp. Neurol. 55 1996 300 309
32. R. Martin, H.F. McFarland, and D.E. McFarlin Immunological aspects of demyelinating diseases Annu. Rev. Immunol. 10 1992 153 187
33. N. Marx, F. Mach, A. Sauty, J.H. Leung, M.N. Sarafi, R.M. Ransohoff, P. Libby, J. Plutzky, and A.D. Luster Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells J. Immunol. 164 2000 6503 6508
34. N. Marx, G. Sukhova, C. Murphy, P. Libby, and J. Plutzky Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro Am. J. Pathol. 153 1998 17 23
35. C. Natarajan, and J.J. Bright Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation Genes Immun. 3 2002 59 70
36. M. Niino, K. Iwabuchi, S. Kikuchi, M. Ato, T. Morohashi, A. Ogata, K. Tashiro, and K. Onoe Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ J. Neuroimmunol. 116 2001 40 48
37. J. Padilla, K. Kaur, H.G. Cao, T.J. Smith, and R.P. Phipps Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells J. Immunol. 12 2000 6941 6948
38. J. Padilla, E. Leung, and R.P. Phipps Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists Clin. Immunol. 103 2002 22 33
39. M.P. Pender, and M.J. Rist Apoptosis in inflammatory cells in immune control of the nervous system Glia 36 2001 137 144
40. H.A. Pershadsingh, M.T. Heneka, R. Saini, N.M. Amin, D.J. Broseske, and D.L. Feinstein Effect of pioglitazone in a patient with secondary multiple sclerosis J. Neuroinflammation 1 2004 3 6
41. 2 Proc. Natl. Acad. Sci. U.S.A. 96 1999 4668 4673
42. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation Nature 391 1998 79 82
43. A. Rossi, P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M.G. Santoro Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase Nature 403 2000 103 108
44. H. Shu, B. Wong, G. Zhou, Y. Li, J. Berger, J.W. Woods, S.D. Wright, and T-Q. Cai Activation of PPARα or γ reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells Biochem. Biophys. Res. Commun. 267 2000 345 349
45. D.S. Straus, and C.K. Glass Cyclopentenone prostaglandins: new insights on biological activities and cellular targets Med. Res. Rev. 21 2001 185 210
46. 2 inhibits multiple steps in the NF-κ B signaling pathway Proc. Natl. Acad. Sci. U. S. A. 97 2000 4844 4849
47. C. Trebst, and R.M. Ransohoff Investigating chemokines and chemokine receptors in patients with multiple sclerosis Arch. Neurol. 58 2001 1975 1980
48. S. Uryu, J. Harada, M. Hisamoto, and T. Oda Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons Brain Res. 924 2002 229 236
49. 2 J. Immunol. 166 2001 7104 7111